New hope for Hard-to-Treat colon cancer? study tests targeted drug combo
Disease control
Terminated
This study tested whether adding the experimental drug ompenaclid to standard chemotherapy could shrink tumors in people with advanced colorectal cancer that has a specific genetic change (RAS mutation). The study was stopped early, so results are limited. It involved 76 adults w…
Phase: PHASE2 • Sponsor: Inspirna, Inc. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC